Advertisement

Topics

CVS Health removes 17 drugs from formulary, adds outcomes-based program

07:18 EDT 2 Aug 2017 | BioPharmaDive

The pharmacy benefit manager put out its 2018 list, removing Lilly's Jardiance while bringing back in Pfizer's Xtandi and J&J's Invokana. 

Original Article: CVS Health removes 17 drugs from formulary, adds outcomes-based program

NEXT ARTICLE

More From BioPortfolio on "CVS Health removes 17 drugs from formulary, adds outcomes-based program"

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...